Published Date: 08 Mar 2023
Medicare covers people with disabilities who are young enough to get pregnant. Contraception is often not covered for these patients and they opt for hysterectomy or tubal ligation, which may be covered.
Read Full NewsA new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...
Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and often leaves patients and their families searching for every possible option.
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection ...
1.
The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.
2.
Knowing about and avoiding bladder cancer.
3.
Hybrid imaging test combines antibody and radioisotope for early lung cancer detection
4.
Alecensa (alectinib) Offers Hope for Certain Patients With ALK Positive NSCLC
5.
A US health panel advises starting mammograms at age 40 rather than 50.
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
3.
Cutting-Edge Cancer Care: The Precision Revolution in Surgical Oncology
4.
Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer
5.
Cardiotoxicity Beyond Anthracyclines: Redefining Risk in the Cardio-Oncology Era
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV
2.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
Navigating the Complexities of Ph Negative ALL - Part XV
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation